(HBOT). However, there is a paucity of data in the literature evaluating the efficacy of (HBOT) following NSM. The purpose of this study is to determine whether HBOT prevents transformation of NAC or SF ischemia to necrosis and complete tissue loss.
METHODS:
After IRB approval, NSM's performed at a single institution from 1989 to 2015 were retrospectively reviewed, individually by breast, for analysis. All NAC and SF ischemia and/or necrosis were identified. Patient demographics, comorbidities, chemo-and radiation therapy, HBOT, and NAC and SF loss (resection or complete tissue loss) were collected. Student's t-test and chi square were used to compare demographics between cohorts, and Fisher's exact test was used to compare rates of progression to necrosis.
RESULTS:
Data for 693 breasts having undergone NSM was reviewed, 63 (9.1%) breasts incurred NAC ischemia and 51 (7.4%) incurred SF ischemia. A total 53.5% had therapeutic NSM, 10.1% received neoadjuvant chemotherapy, 40.4% received adjuvant chemotherapy, and 13.3% received adjuvant radiation therapy. Due to an overlap between NAC and SF ischemia, final cohort size consisted of 99 breasts. There were 12 NAC's and 15 skin flaps that developed necrosis and were resected. The mean age was 46.0 ± 9.2 years, BMI was 23.8 ± 3.8 kg/m 2 , 8.1% were active smokers until diagnosis, 3% had type 2 diabetes mellitus, and mean breast weight was 414 ± 212g. All patients underwent immediate breast reconstruction, of whom 79.8% had tissue expanders placed with a mean initial fill volume of 247 ± 104ml, 10.1% had tissue expanders, which were not filled during initial placement, and 10.1% received direct implant reconstruction with mean volume of 443.5 ± 207ml. HBOT was implemented for 12.7% (n = 8) of breasts with NAC ischemia and 23.5% (n = 12) with SF ischemia, while the remaining breasts received local wound care. Mean number of HBOT dives completed was 14.8 ± 3.8. Of breasts with NAC ischemia, progression to necrosis was similar whether HBOT was implemented or not (25.0% vs. 18.2%, respectively; p = 0.64). Breasts with SF ischemia and HBOT progressed to SF necrosis at a higher rate compared to those not receiving HBOT (75.0% vs 15.4%, respectively; p < 0.01).
CONCLUSION:
Hyperbaric oxygen therapy does not appear to prevent the progression of NAC or SF ischemia to necrosis as compared to patients not receiving HBOT following NSM. Although there may be a selection bias of those undergoing HBOT, the use of HBOT needs to be further delineated to support HBOT implementation following ischemia of the NAC or SF after NSM. 
Chlorhexidine Gluconate Surgical Preparation is Associated with Increases in the Proportion of Streptococcus Species and Enterobacteriaceae Genera in Skin Microbiome
Sifon Ndon, AB 1 PURPOSE: Post-surgical infections are amongst the most common post-surgical complications and can cause significant morbidity and mortality for patients. This study sought to better characterize the effect of surgical skin preparation on the skin microbiome and understand how such changes may be related to surgical site infections.
METHODS:
Surgical site skin swabs were collected from consenting women aged years or older undergoing breast reconstructive surgery over a 2-month period at Yale New Haven Hospital. Swabs were obtained immediately prior to and approximately 1 minute after skin sterilization with ChloraPrep. Surgical sites were swabbed for 15-20 seconds with sterile cotton-tipped swabs soaked in an enzymatic lysis buffer (20mM Tris pH 8, 2nM EDTA, 1.2% Triton X-100). Swabs were placed into 1.5ml sterile Eppendorf tubes and stored at -80°C until further processing. DNA was extracted using the Invitrogen Purelink Genomic DNA kit. PCR amplification of bacterial genomic DNA was done with Phusion polymerase using primers targeted to the 16S V1-V3 hypervariable regions. Bacterial genomic sequencing was performed with the Illumina MiSeq platform. A Wilcoxon Signed-Rank test was used to compare pre and post-surgical preparation skin microbiome composition with particular focus on the predominant organisms in normal skin flora.
RESULTS:
A total of 36 samples (18 pre-prep and 18 postprep) from 9 patients were obtained and sequenced. On average, 20 operational taxonomic units (SD 7.4) were found within each sample. In each pre-prep sample, Streptococcus species comprised an average of 1.5% (SD 0.1) and Enterobacteriaceae genera comprised an average of 4.2% (5.7) of the skin microbiome. In each post-prep sample, Streptococcus species comprised an average of 3.7% (SD 3.8) and Enterobacteriaceae genera comprised an average of 14.1% (12.6) of the skin microbiome. Wilcoxon Signed Rank test indicated that post-prep proportions were statistically significantly higher than pre-prep proportions for Streptococcus species (S= 56, p=0.0063) and Enterobacteriaceae genera (S=79.5, p<0.0001). There was no statistically significant pre-and post-prep difference in the proportion of Staphylococcus and Corynebacterium species, which are also known to be components of normal skin flora.
CONCLUSIONS:
The use of ChloraPrep appears to have differential bactericidal/bacteriostatic effects on certain microorganisms, leading to an increase in the proportion of the overall skin microbiome comprised by Streptococcus species and members of the Enterobacteriaceae genera, both of which have been implicated in surgical site infections. Appropriate perioperative antibiotic dosing should be employed to potentially decrease the risk of such infections.
